ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PRLD Prelude Therapeutics Inc

3.86
-0.13 (-3.26%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 17,251
Bid Price 2.02
Ask Price 5.50
News -
Day High 4.11

Low
1.66

52 Week Range

High
6.89

Day Low 3.795
Share Name Share Symbol Market Stock Type
Prelude Therapeutics Inc PRLD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.13 -3.26% 3.86 23:00:02
Open Price Low Price High Price Close Price Previous Close
4.03 3.795 4.11 3.86 3.99
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
439 17,251 US$ 3.97 US$ 68,557 - 1.66 - 6.89
Last Trade Type Quantity Price Currency
15:02:10 priorref 533 US$ 3.86 USD

Prelude Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
211.99M 54.92M - 0 -121.83M -2.22 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Prelude Therapeutics News

Date Time Source News Article
4/09/202415:35GlobeNewswire Inc.Prelude Highlights Continued Strength of Discovery Engine at..
3/05/202415:45GlobeNewswire Inc.Prelude Announces Acceptance of Multiple Preclinical..
3/04/202417:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202417:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202417:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:05GlobeNewswire Inc.Prelude Therapeutics to Participate in Barclays Global..
2/15/202416:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202415:22Edgar (US Regulatory)Form 8-K - Current report
2/15/202415:05GlobeNewswire Inc.Prelude Therapeutics Reports Full Year 2023 Financial..
2/12/202415:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRLD Message Board. Create One! See More Posts on PRLD Message Board See More Message Board Posts

Historical PRLD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.044.113.563.8627,010-0.18-4.46%
1 Month4.675.833.424.3647,362-0.81-17.34%
3 Months2.625.832.624.1966,9171.2447.33%
6 Months2.315.832.053.57113,1631.5567.10%
1 Year6.366.891.663.71124,542-2.50-39.31%
3 Years41.4445.331.6613.45188,245-37.58-90.69%
5 Years25.7695.3751.6620.72191,584-21.90-85.02%

Prelude Therapeutics Description

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Your Recent History

Delayed Upgrade Clock